Emerging Therapies in Sight for the Fight against Dedifferentiated Thyroid Cancer

被引：8

作者：

Benvenga, Salvatore ^{[1
]}

机构：

[1] Univ Messina, Sch Med, Dept Expt & Clin Med & Pharmacol, Sect Endocrinol,Policlin Univ, I-98125 Messina, Italy

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2011年 / 96卷 / 02期

关键词：

PHASE-II TRIAL; CELL-LINES; SORAFENIB; CARCINOMA;

D O I：

10.1210/jc.2010-2799

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：347 / 350

页数：4

共 20 条

[1] Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration [J].

Antonelli, Alessandro ;

Ferrari, Silvia Martina ;

Fallahi, Poupak ;

Berti, Piero ;

Materazzi, Gabriele ;

Marchetti, Ivo ;

Ugolini, Clara ;

Basolo, Fulvio ;

Miccoli, Paolo ;

Ferrannini, Ele .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 159 (03) :283-291

[2] Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests [J].

Antonelli, Alessandro ;

Ferrari, Silvia Martina ;

Fallahi, Poupak ;

Berti, Piero ;

Materazzi, Gabriele ;

Barani, Lucio ;

Marchetti, Ivo ;

Ferrannini, Ele ;

Miccoli, Paolo .

CLINICAL ENDOCRINOLOGY, 2008, 69 (01) :148-152

[3] New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer [J].

Antonelli, Alessandro ;

Ferri, Clodoveo ;

Ferrari, Silvia Martina ;

Sebastiani, Marco ;

Colaci, Michele ;

Ruffilli, Ilaria ;

Fallahi, Poupak .

JOURNAL OF ONCOLOGY, 2010, 2010

[4] Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer [J].

Antonelli, Alessandro ;

Bocci, Guido ;

La Motta, Concettina ;

Ferrari, Silvia Martina ;

Fallahi, Poupak ;

Fioravanti, Anna ;

Sartini, Stefania ;

Minuto, Michele ;

Piaggi, Simona ;

Corti, Alessandro ;

Ali, Greta ;

Berti, Piero ;

Fontanini, Gabriella ;

Danesi, Romano ;

Da Settimo, Federico ;

Miccoli, Paolo .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (02) :E288-E296

[5] New therapeutic approaches for metastatic thyroid carcinoma [J].

Baudin, Eric ;

Schlumberger, Martin .

LANCET ONCOLOGY, 2007, 8 (02) :148-156

[6] Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study [J].

Bible, Keith C. ;

Suman, Vera J. ;

Molina, Julian R. ;

Smallridge, Robert C. ;

Maples, William J. ;

Menefee, Michael E. ;

Rubin, Joseph ;

Sideras, Kostandinos ;

Morris, John C., III ;

McIver, Bryan ;

Burton, Jill K. ;

Webster, Kevin P. ;

Bieber, Carolyn ;

Traynor, Anne M. ;

Flynn, Patrick J. ;

Goh, Boon Cher ;

Tang, Hui ;

Ivy, Susan Percy ;

Erlichman, Charles .

LANCET ONCOLOGY, 2010, 11 (10) :962-972

[7] Methods and goals for the use of in vitro and in vivo chemosensitivity testing [J].

Blumenthal, Rosalyn D. ;

Goldenberg, David M. .

MOLECULAR BIOTECHNOLOGY, 2007, 35 (02) :185-197

[8] Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].

Cooper, David S. ;

Doherty, Gerard M. ;

Haugen, Bryan R. ;

Kloos, Richard T. ;

Lee, Stephanie L. ;

Mandel, Susan J. ;

Mazzaferri, Ernest L. ;

McIver, Bryan ;

Pacini, Furio ;

Schlumberger, Martin ;

Sherman, Steven I. ;

Steward, David L. ;

Tuttle, R. Michael .

THYROID, 2009, 19 (11) :1167-1214

[9] Effects of Silencing RET/PTC1 Junction Oncogene in Human Papillary Thyroid Carcinoma Cells [J].

Gilbert-Sirieix, Marie ;

Ripoche, Hugues ;

Malvy, Claude ;

Massaad-Massade, Liliane .

THYROID, 2010, 20 (10) :1053-1065

[10] Phase II trial of sorafenib in advanced thyroid cancer [J].

Gupta-Abramson, Vandana ;

Troxel, Andrea B. ;

Nellore, Anoma ;

Puttaswamy, Kanchan ;

Redlinger, Maryann ;

Ransone, Kathy ;

Mandel, Susan J. ;

Flaherty, Keith T. ;

Loevner, Laurie A. ;

O'Dwyer, Peter J. ;

Brose, Marcia S. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) :4714-4719

← 1 2 →